Jim Cramer’s Game Plan: 17 Stocks in Focus

Page 12 of 16

5. Hims & Hers Health, Inc. (NYSE:HIMS)

Number of Hedge Fund Holders: 38

Cramer highlighted the chatter around whether Hims & Hers Health, Inc. (NYSE:HIMS) will be able to offer cheaper alternatives to GLP-1 drugs.

“Finally, I have to tell you there’s one stock that’s become a true battleground here and I don’t mean Palantir. I’m talking about a stock called Hims & Hers Health. That’s an online healthcare company that currently offers a less expensive alternative to the GLP-1 weight loss drugs as long as they’re relatively unavailable. Now today the FDA said that Novo Nordisk GLP-1 formulation is no longer in short supply, which, which could mean that the compounding pharmacies that are making similar versions of the drug have to stop.

Now Hims & Hers has said it can still make the cheaper version some way, but the market seems skeptical. Hence the stock’s astounding 26% collapse today. But then again, it’s still up more than a 100% year to date so profit-taking… makes sense to me.”

Hims & Hers Health (NYSE:HIMS) offers a telehealth platform that delivers both prescription and over-the-counter health and wellness products and services, such as medication, skincare, sexual health, hair care, and wellness items, along with continuous support from licensed healthcare providers.

Page 12 of 16
1281292 - 11759070 - 1